Looking At Pfizer's Recent Whale Trades

Someone with a lot of money to spend has taken a bearish stance on Pfizer PFE.

And retail traders should know.

We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Whether this is an institution or just a wealthy individual, we don't know. But when something this big happens with PFE, it often means somebody knows something is about to happen.

So how do we know what this whale just did?

Today, Benzinga's options scanner spotted 21 uncommon options trades for Pfizer.

This isn't normal.

The overall sentiment of these big-money traders is split between 42.86% bullish and 57.14%, bearish.

Out of all of the special options we uncovered, 2 are puts, for a total amount of $89,343.00, and 19 are calls, for a total amount of $1,016,202.00.

What's The Price Target?

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $45.0 to $56.0 for Pfizer over the last 3 months.

Volume & Open Interest Development

Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.

This data can help you track the liquidity and interest for Pfizer's options for a given strike price.

Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Pfizer's whale activity within a strike price range from $45.0 to $56.0 in the last 30 days.

Pfizer Option Volume And Open Interest Over Last 30 Days

Biggest Options Spotted:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trade Price Open Interest Volume
PFE CALL TRADE BULLISH 01/20/23 $45.00 $181.5K 15.0K 207
PFE CALL SWEEP BEARISH 12/17/21 $54.00 $109.7K 2.9K 1.0K
PFE CALL TRADE BULLISH 03/18/22 $50.00 $71.5K 27.7K 203
PFE PUT SWEEP BULLISH 01/21/22 $50.00 $60.7K 15.8K 2.8K
PFE CALL TRADE BEARISH 12/10/21 $48.00 $59.4K 841 307

Where Is Pfizer Standing Right Now?

  • With a volume of 21,471,314.00, the price of PFE is up 0.6% at $54.05.
  • RSI indicators hint that the underlying stock may be overbought.
  • Next earnings are expected to be released in 62 days.

What The Experts Say On Pfizer:

  • BMO Capital downgraded its action to Outperform with a price target of $60.0
  • Morgan Stanley has decided to maintain their Equal-Weight rating on Pfizer, which currently sits at a price target of $60.0.
  • SVB Leerink has decided to maintain their Market Perform rating on Pfizer, which currently sits at a price target of $48.0.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you are already an options trader or would like to get started, head on over to Benzinga Pro. Benzinga Pro gives you up-to-date news and analytics to empower your investing and trading strategy.

Market News and Data brought to you by Benzinga APIs
Date of Trade
▲▼
ticker
▲▼
Put/Call
▲▼
Strike Price
▲▼
DTE
▲▼
Sentiment
▲▼
Posted In: OptionsMarketsBZI-UOA
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...